MAPK1 and neoplasm: Therefore, the close association of the RAS–ERK signaling activation with various clinical tumors together with the findings that the blockade of ERK signaling by specific inhibitors of RAF or MEK suppress tumor proliferation at the clinical level are consistent with the well-recognized concept that RAS–ERK pathway activation exerts anti-apoptotic functions.